These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18175092)

  • 21. [Cardioprotection by anesthetics].
    Hara T
    Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophied hearts: what of sevoflurane cardioprotection?
    Larsen JR; Smerup M; Hasenkam JM; Christensen SD; Sivesgaard K; Torp P; Sloth E
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):496-504. PubMed ID: 19317865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of free radicals in the myocardial reperfusion injuries and in the development of endogenous adaptation].
    Rőth E
    Orv Hetil; 2015 Nov; 156(47):1908-11. PubMed ID: 26568105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postconditioning: reduction of reperfusion-induced injury.
    Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Strategy and perspective of myocardial protection during ischaemia and reperfusion, and the role of volatile anaesthetics].
    Jović M; Krivokapić B; Lausević-Vuk L; Nezić D; Stevanović P
    Srp Arh Celok Lek; 2007; 135(9-10):583-8. PubMed ID: 18088047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischaemic preconditioning: from molecular characterisation to clinical application--part II.
    Riksen NP; Smits P; Rongen GA
    Neth J Med; 2004 Dec; 62(11):409-23. PubMed ID: 15685892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiology and pharmacology of myocardial preconditioning.
    Raphael J
    Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):54-9. PubMed ID: 20472628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The coronary circulation in cardioprotection: more than just one confounder.
    Heusch G; Kleinbongard P; Skyschally A; Levkau B; Schulz R; Erbel R
    Cardiovasc Res; 2012 May; 94(2):237-45. PubMed ID: 22002502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection in the aged heart: preventing the heart-break of old age?
    Juhaszova M; Rabuel C; Zorov DB; Lakatta EG; Sollott SJ
    Cardiovasc Res; 2005 May; 66(2):233-44. PubMed ID: 15820192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioprotection by volatile anesthetics: new applications for old drugs?
    Pratt PF; Wang C; Weihrauch D; Bienengraeber MW; Kersten JR; Pagel PS; Warltier DC
    Curr Opin Anaesthesiol; 2006 Aug; 19(4):397-403. PubMed ID: 16829721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
    Vinten-Johansen J; Shi W
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial ischemia and reperfusion injury.
    Buja LM
    Cardiovasc Pathol; 2005; 14(4):170-5. PubMed ID: 16009313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury.
    Banz Y; Hess OM; Robson SC; Mettler D; Meier P; Haeberli A; Csizmadia E; Korchagina EY; Bovin NV; Rieben R
    Eur Heart J; 2005 Nov; 26(21):2334-43. PubMed ID: 16055495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Organ protection by conditioning].
    Bein B; Meybohm P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):254-61; quiz 262. PubMed ID: 20387183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase.
    Kamota T; Li TS; Morikage N; Murakami M; Ohshima M; Kubo M; Kobayashi T; Mikamo A; Ikeda Y; Matsuzaki M; Hamano K
    J Am Coll Cardiol; 2009 May; 53(19):1814-22. PubMed ID: 19422991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury.
    Powers SK; Quindry JC; Kavazis AN
    Free Radic Biol Med; 2008 Jan; 44(2):193-201. PubMed ID: 18191755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.